DOWNLOAD THE AGENDA:
14th Semi-Annual Diagnostic Coverage and Reimbursement Conference

February 12-13, 2019 | San Diego, CA

 

Please Complete the Form to Download the Agenda

ABOUT THE CONFERENCE

Within the rapidly evolving healthcare market, test developers and laboratories face unique challenges in obtaining reimbursement for new diagnostics as payers’ focus increasingly shifts towards cost-efficiency as a priority, in addition to optimized patient outcomes. The necessity to prove value in direct relation to a specific health condition’s market economics is more important than ever before, implying robust evidence not only of scientific benefits but also optimized cost-savings. In the effort of continuously developing evidence-targeted reimbursement strategies, ensuring a clear understanding of Laboratory Benefit Managers’ role is also pivotal to maximize chances of positive decisions and satisfactory coverage. The rapid rise in payer demands for diagnostic test prior authorization also create a new landscape for the industry, raising many questions about the process and overall responsibility.

The 13th and 14th editions of the renowned Q1 Diagnostic Coverage & Reimbursement Conference will once more dive deep into a variety of pressing matters, also including updated insight into policies such as PAMA entering the new consultation period, how to access NCDs as well as a comprehensive approach to value-based agreements with payers. Through a multitude of perspectives including private and public payers, LBMs, thought industry leaders and legal partners, topics of critical importance will be addressed with a holistic approach. To ensure the highest level of education possible, the audience will also have an opportunity to gather in peer-to-peer learning groups, enabling an exclusive and engaging platform to exchange knowledge and experience in test-specific challenges making this semi-annual conference series a must-attend.

TOPICS TO BE ADDRESSED INCLUDE:

  • Clarifying evolving challenges with diagnostic test prior authorizations
  • Establishing an economic rationale for test inclusion in payer networks
  • Comprehensive approach to CPT code challenges & opportunities in PLAs
  • Evidence focus: impactful clinical study design & defining evidence quality
  • Deciphering LBMs’ role & evaluation methods to maximize positive reviews
  • Clarifying evolving requirements from the private & public payer perspectives
  • Rising OTC & mobile self-tests: Impact on the industry & reimbursement policies
  • Diagnostics industry advocacy, lobbying & initiatives in engaging with government
  • The impact of increasing industry & payer value-based agreements on the industry
  • Forecast of the impact of mid-term elections on healthcare reimbursement policies
  • Clarifying the alignment of CMS & commercial payer reimbursements or lack thereof
  • Proactive approach to diagnostics’ position in the rapidly evolving healthcare market
  • Achieving NCD: Analysis of strategies from both large & small laboratory perspectives
  • Test-specific challenges: Exchanging insight & experience in each diagnostic specialty
  • Healthcare market intelligence collection methods to keep abreast of impactful trends
  • Diving into PAMA & Medicare policy updates & the impact on diagnostic reimbursement
  • Industry case studies: The journey towards securing successful reimbursement decisions

WHO SHOULD ATTEND

Executives that will be most interested in participating in this conference program will be those involved in securing reimbursement for new or existing diagnostic tests. Job titles of executives that will be most applicable for this program include VPs, Directors and Managers of:

  • Reimbursement
  • Health Policy
  • Government Affairs
  • Payer Relations/Strategy
  • National Accounts
  • Contracting
  • Billing
  • Managed Care
  • Revenue Cycle Management

ABOUT THE CONFERENCE

The 13th and 14th editions of the renowned Q1 Diagnostic Coverage & Reimbursement Conference will once more dive deep into a variety of pressing matters, also including updated insight into policies such as PAMA entering the new consultation period, how to access NCDs as well as a comprehensive approach to value-based agreements with payers. Through a multitude of perspectives including private and public payers, LBMs, thought industry leaders and legal partners, topics of critical importance will be addressed with a holistic approach. To ensure the highest level of education possible, the audience will also have an opportunity to gather in peer-to-peer learning groups, enabling an exclusive and engaging platform to exchange knowledge and experience in test-specific challenges making this semi-annual conference series a must-attend.

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Share This